Biotechnology & Biotechnological Equipment (Jan 2021)

ELISA-based competitive trypsin inhibition assay

  • Bengü Ergenoğlu,
  • Özlem Ertekin,
  • Şerife Şeyda Pirinçci Göktürk,
  • Göknur Gizem Dinç,
  • Esin Akçael,
  • Melahat Bağirova,
  • Fatıma Yücel

DOI
https://doi.org/10.1080/13102818.2021.1977697
Journal volume & issue
Vol. 35, no. 1
pp. 1385 – 1392

Abstract

Read online

Proteolytic enzymes are crucial for numerous biological processes and are tightly controlled by specific inhibitors. In addition to the research activities to investigate the natural effects of these inhibitors, it is important to determine the inhibition capabilities of inhibitors due to their importance in different fields, including food and health industry. In this study, we describe a high-throughput adaptable screening method to detect inhibitors and compare their inhibition efficiency at nanogram levels, using a Competitive enzyme-linked immunosorbent assay (ELISA) based Trypsin Inhibition Assay (E-CTIA). We worked with four different inhibitors from different sources and action mechanisms, all of which were competitive inhibitors. The half-maximal inhibitory concentration (IC50) strongly correlated with the experimental inhibition capacities introduced in the user manuals. E-CTIA successfully fulfills the requirements of an assay, such as reproducibility, low cost, low sample requirement and ease of use. It also enables to test multiple samples simultaneously in a short time, and it has the potential to be adapted to bigger plate formats such as 384 well or even bigger. Besides being the first successful example of Competitive ELISA Based Inhibition Assay, it has the potential to be used for many competitive inhibitors.

Keywords